IDEXX Laboratories Net Income 2010-2025 | IDXX
IDEXX Laboratories annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- IDEXX Laboratories net income for the quarter ending June 30, 2025 was $0.294B, a 44.61% increase year-over-year.
- IDEXX Laboratories net income for the twelve months ending June 30, 2025 was $0.986B, a 16.56% increase year-over-year.
- IDEXX Laboratories annual net income for 2024 was $0.888B, a 5.07% increase from 2023.
- IDEXX Laboratories annual net income for 2023 was $0.845B, a 24.44% increase from 2022.
- IDEXX Laboratories annual net income for 2022 was $0.679B, a 8.83% decline from 2021.
| IDEXX Laboratories Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $888 |
| 2023 | $845 |
| 2022 | $679 |
| 2021 | $745 |
| 2020 | $582 |
| 2019 | $428 |
| 2018 | $377 |
| 2017 | $263 |
| 2016 | $222 |
| 2015 | $192 |
| 2014 | $182 |
| 2013 | $188 |
| 2012 | $178 |
| 2011 | $162 |
| 2010 | $141 |
| 2009 | $122 |
| IDEXX Laboratories Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $294 |
| 2025-03-31 | $243 |
| 2024-12-31 | $216 |
| 2024-09-30 | $233 |
| 2024-06-30 | $203 |
| 2024-03-31 | $236 |
| 2023-12-31 | $195 |
| 2023-09-30 | $212 |
| 2023-06-30 | $224 |
| 2023-03-31 | $214 |
| 2022-12-31 | $172 |
| 2022-09-30 | $181 |
| 2022-06-30 | $132 |
| 2022-03-31 | $194 |
| 2021-12-31 | $163 |
| 2021-09-30 | $175 |
| 2021-06-30 | $203 |
| 2021-03-31 | $204 |
| 2020-12-31 | $175 |
| 2020-09-30 | $146 |
| 2020-06-30 | $149 |
| 2020-03-31 | $112 |
| 2019-12-31 | $90 |
| 2019-09-30 | $109 |
| 2019-06-30 | $126 |
| 2019-03-31 | $103 |
| 2018-12-31 | $86 |
| 2018-09-30 | $93 |
| 2018-06-30 | $109 |
| 2018-03-31 | $89 |
| 2017-12-31 | $38 |
| 2017-09-30 | $71 |
| 2017-06-30 | $85 |
| 2017-03-31 | $69 |
| 2016-12-31 | $52 |
| 2016-09-30 | $56 |
| 2016-06-30 | $67 |
| 2016-03-31 | $46 |
| 2015-12-31 | $44 |
| 2015-09-30 | $44 |
| 2015-06-30 | $57 |
| 2015-03-31 | $47 |
| 2014-12-31 | $26 |
| 2014-09-30 | $52 |
| 2014-06-30 | $57 |
| 2014-03-31 | $47 |
| 2013-12-31 | $43 |
| 2013-09-30 | $46 |
| 2013-06-30 | $54 |
| 2013-03-31 | $45 |
| 2012-12-31 | $43 |
| 2012-09-30 | $43 |
| 2012-06-30 | $51 |
| 2012-03-31 | $41 |
| 2011-12-31 | $38 |
| 2011-09-30 | $39 |
| 2011-06-30 | $49 |
| 2011-03-31 | $37 |
| 2010-12-31 | $36 |
| 2010-09-30 | $35 |
| 2010-06-30 | $37 |
| 2010-03-31 | $33 |
| 2009-12-31 | $31 |
| 2009-09-30 | $32 |
| 2009-06-30 | $34 |
| 2009-03-31 | $26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.765B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| DexCom (DXCM) | United States | $29.443B | 44.17 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| Waters (WAT) | United States | $17.717B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |